EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipids as Targets for Renal Cell Carcinoma Therapy

Bisera Stepanovska Tanturovska, Roxana Manaila, Doriano Fabbro, Andrea Huwiler iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043272 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Bisera Stepanovska Tanturovska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010 Bern, Switzerland. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 220 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney cancer is among the top ten most common cancers to date. Within the kidney, renal cell carcinoma (RCC) is the most common solid lesion occurring. While various risk factors are suspected, including unhealthy lifestyle, age, and ethnicity, genetic mutations seem to be a key risk factor. In particular, mutations in the von Hippel–Lindau gene (Vhl) have attracted a lot of interest since this gene regulates the hypoxia inducible transcription factors HIF-1α and HIF-2α, which in turn drive the transcription of many genes that are important for renal cancer growth and progression, including genes involved in lipid metabolism and signaling. Recent data suggest that HIF-1/2 are themselves regulated by bioactive lipids which make the connection between lipids and renal cancer obvious. This review will summarize the effects and contributions of the different classes of bioactive lipids, including sphingolipids, glycosphingolipids, eicosanoids, free fatty acids, cannabinoids, and cholesterol to renal carcinoma progression. Novel pharmacological strategies interfering with lipid signaling to treat renal cancer will be highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansBasic Helix-Loop-Helix ProteinsGene Expression Regulation, NeoplasticHypoxia-Inducible Factor 1, alpha SubunitLipidsVon Hippel-Lindau Tumor Suppressor Protein

Stichwörter der Autor:innen

cannabinoidscholesteroleicosanoidsfree fatty acidsglycosphingolipidskidney cancerlipidsrenal cell carcinomasphingolipids

Substanzen

Basic Helix-Loop-Helix ProteinsHypoxia-Inducible Factor 1, alpha SubunitLipidsVon Hippel-Lindau Tumor Suppressor Protein

Autor:innen und Institutionen

  • Institute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010 Bern, Switzerland.
  • Cellestia Biotech AG, Technology Park Basel, Hochbergerstrasse 60C, CH-4057 Basel, Switzerland.

ORCID-Profile: Andrea Huwiler

Zitieren

APA

Stepanovska Tanturovska, B., Manaila, R., Fabbro, D., & Huwiler, A. (2023). Lipids as Targets for Renal Cell Carcinoma Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043272

Vancouver

Stepanovska Tanturovska B, Manaila R, Fabbro D, Huwiler A. Lipids as Targets for Renal Cell Carcinoma Therapy. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043272

BibTeX
@article{StepanovskaTanturovska2023,
  author = {Stepanovska Tanturovska, Bisera and Manaila, Roxana and Fabbro, Doriano and Huwiler, Andrea},
  title = {Lipids as Targets for Renal Cell Carcinoma Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043272}
}
Kostenlos starten →